|
시장보고서
상품코드
1741401
진단용 방사성 동위 원소 시장 : 방사성 동위 원소별, 용도별, 이미징 모달리티별, 적응증별, 최종사용자별, 지역별Diagnostic Radioisotopes Market, By Radioisotope, By Application, By Imaging Modality, By Disease Indication, By End User, By Geography |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
진단용 방사성 동위 원소 시장은 2025년 67억 4,000만 달러, 2032년에는 123억 2,000만 달러에 이르고, 2025-2032년 연평균 복합 성장률(CAGR)로 9%의 성장이 예측됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 | 2024 | 2025년 시장 규모 | 67억 4,000만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2025-2032년 |
| 예측 기간(2025-2032년) CAGR | 9.00% | 2032년 가치 예측 | 123억 2,000만 달러 |
진단용 방사성 동위원소 세계 시장은 만성 질환의 유병률 증가, 의료 영상 기술의 발전, 정확한 진단 절차에 대한 수요 증가로 인해 괄목할 만한 성장세를 보이고 있습니다. 진단용 방사성 동위원소는 다양한 질병과 상태를 진단하기 위한 의료 영상 진단에 사용되는 방사성 물질입니다. 이 방사성 동위원소는 방사선을 방출하고 영상진단 장비에서 감지할 수 있기 때문에 의료 전문가가 신체 내부 구조를 시각화하고 분석할 수 있습니다.
시장 역학:
세계 진단용 방사성 동위원소 시장 시장 역학은 몇 가지 요인에 의해 영향을 받습니다. 암, 심혈관 질환, 신경 장애와 같은 만성 질환의 유병률 증가는 진단용 방사성 동위원소에 대한 수요를 견인하고 있습니다. 이러한 방사성 동위원소는 양전자방사선단층촬영(PET), 단광자방사선전산화단층촬영(SPECT), 감마카메라 등 다양한 영상진단기술에 사용되어 이러한 질병을 검출하고 진단합니다.
그러나 시장 성장을 저해하는 요인도 있습니다. 진단용 방사성 동위원소의 높은 비용과 제조 및 사용에 대한 엄격한 규제 요건이 시장 성장의 걸림돌로 작용하고 있습니다. 또한, 사용 가능한 방사성 동위원소가 한정되어 있고 일부 동위원소의 반감기가 짧기 때문에 특정 진단 절차에 대한 사용이 제한될 수 있습니다.
이러한 어려움에도 불구하고, 시장에는 몇 가지 성장 기회가 있으며, PET/CT 및 SPECT/CT와 같은 하이브리드 이미징 기술의 채택이 증가함에 따라 진단용 방사성 동위원소 수요를 견인할 것으로 예측됩니다. 또한, 신규 방사성 동위원소 및 방사성의약품의 개발, 이미징 기술의 발전은 시장에 새로운 기회를 창출할 것으로 예측됩니다.
본 조사의 주요 특징
- 세계의 진단용 방사성 동위원소 시장을 상세하게 분석하여 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모와 연평균 성장률(CAGR)을 조사 분석하여 전해드립니다.
- 또한, 다양한 부문에 걸친 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
- 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 진단용 방사성 동위원소 시장의 주요 기업을 프로파일링합니다.
- 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- 세계 진단용 라디오 동위원소 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 진단용 방사성 동위원소 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 조사 목적과 전제조건
- 조사 목적
- 전제조건
- 약어
제2장 시장 전망
- 보고서 설명
- 시장 정의와 범위
- 주요 요약
- Coherent Opportunity Map(COM)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 성장 촉진요인
- 성장 억제요인
- 기회
- 영향 분석
- 주요 하이라이트
- 규제 시나리오
- 제품 발매 및 승인
- PEST 분석
- PORTER 분석
- 인수합병(M&A) 시나리오
제4장 세계의 진단용 방사성 동위 원소 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향
- COVID-19 역학
- 공급측과 수요측 분석
- 경제에 대한 영향
제5장 세계의 진단용 방사성 동위 원소 시장, 방사성 동위 원소별, 2020년-2032년
- Technetium-99m
- Thallium-201
- Gallium-67
- Iodine-123
- FDG
- Rubidium-82
- 기타
제6장 세계의 진단용 방사성 동위 원소 시장, 용도별, 2020년-2032년
- 진단 용도
- 치료 용도
제7장 세계의 진단용 방사성 동위 원소 시장, 이미징 모달리티별, 2020년-2032년
- SPECT
- PET
- 베타 방사체
제8장 세계의 진단용 방사성 동위 원소 시장, 적응증별, 2020년-2032년
- 종양
- 심장병
- 신경
- 갑상선
- 정형외과
- 내분비
- 기타
제9장 세계의 진단용 방사성 동위 원소 시장, 최종사용자별, 2020년-2032년
- 병원
- 전문 클리닉
- 진단센터
- 학술연구기관
- 기타
제10장 세계의 진단용 방사성 동위 원소 시장, 지역별, 2020년-2032년
- 북미
- 미국
- 캐나다
- 유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 라틴아메리카
- 브라질
- 아르헨티나
- 멕시코
- 기타 라틴아메리카
- 중동
- GCC 국가
- 이스라엘
- 기타 중동
- 아프리카
- 남아프리카
- 북아프리카
- 중앙아프리카
제11장 경쟁 구도
- GE Healthcare
- Siemens Healthineers
- Koninklijke Philips N.V.
- Cardinal Health
- Lantheus Holdings, Inc.
- Bayer AG
- Bracco
- Eckert & Ziegler
- Nordion(Canada) Inc.
- NTP Radioisotopes
- Curium
- Jubilant Life Sciences Ltd
- IRE
- Isotopia Molecular Imaging Ltd.
- Mallinckrodt Nuclear Medicine LLC
- Jubilant DraxImage Inc.
- Sumitomo Heavy Industries, Ltd.
- Telix Pharmaceuticals Limited
제12장 섹션
- 조사 방법
- 출판사에 대해
Diagnostic Radioisotopes Market is estimated to be valued at USD 6.74 Bn in 2025 and is expected to reach USD 12.32 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 6.74 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 9.00% | 2032 Value Projection: | USD 12.32 Bn |
The global market for diagnostic radioisotopes is experiencing significant growth due to the increasing prevalence of chronic diseases, advancements in medical imaging technology, and the rising demand for accurate diagnostic procedures. Diagnostic radioisotopes are radioactive substances that are used in medical imaging to diagnose various diseases and conditions. These isotopes emit radiation that can be detected by imaging devices, allowing healthcare professionals to visualize and analyze the internal structures of the body.
Market Dynamics:
The market dynamics of the global diagnostic radioisotopes market are influenced by several factors. The increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders is driving the demand for diagnostic radioisotopes. These isotopes are used in various imaging techniques such as positron emission tomography (PET), single-photon emission computed tomography (SPECT), and gamma cameras to detect and diagnose these diseases.
However, there are certain restraints that may hinder the growth of the market. The high cost of diagnostic radioisotopes and the stringent regulatory requirements for their production and use pose challenges for market growth. Additionally, the limited availability of radioisotopes and the short half-life of some isotopes may limit their use in certain diagnostic procedures.
Despite these challenges, the market presents several opportunities for growth. The increasing adoption of hybrid imaging techniques, such as PET/CT and SPECT/CT, is expected to drive the demand for diagnostic radioisotopes. Moreover, the development of novel radioisotopes and radiopharmaceuticals, as well as advancements in imaging technology, are expected to create new opportunities in the market.
Key features of the study:
- This report provides in-depth analysis of the global diagnostic radioisotopes market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global diagnostic radioisotopes market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include GE Healthcare, Siemens Healthineers, Philips Healthcare , Cardinal Health , Lantheus Medical Imaging, Bayer AG, Bracco Imaging, EczacIbasI-Monrol Nuclear Products , Nordion, Advanced Accelerator Applications, NTP Radioisotopes, Curium Pharma, Jubilant Life Sciences Ltd , IRE - IRE ELiT - Instituto de Pesquisas Energeticas e Nucleares, Australian Nuclear Science and Technology Organisation (ANSTO), Eckert & Ziegler Radiopharma GmbH, Isotopia Molecular Imaging Ltd. , Institute of Atomic Energy of Bangladesh , Rosatom State Atomic Energy Corporation, Board of Radiation and Isotope Technology (BRIT)
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global diagnostic radioisotopes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global diagnostic radioisotopes market
Detailed Segmentation:
- Global Diagnostic Radioisotopes Market, By Radioisotope
- Technetium-99m
- Thallium-201
- Gallium-67
- Iodine-123
- FDG
- Rubidium-82
- Others
- Global Diagnostic Radioisotopes Market, By Application
- Diagnostic Application
- Therapeutic Application
- Global Diagnostic Radioisotopes Market, By Imaging Modality
- SPECT
- PET
- Beta Emitters
- Global Diagnostic Radioisotopes Market, By End User
- Hospitals
- Diagnostic Centers
- Research Institutes
- Others
- Global Diagnostic Radioisotopes Market, By Indication
- Cardiology
- Oncology
- Neurology
- Others
- Global Diagnostic Radioisotopes Market, By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
- Company Profile:
- GE Healthcare
- Siemens Healthineers
- Philips Healthcare
- Cardinal Health
- Lantheus Medical Imaging
- Bayer AG
- Bracco Imaging
- EczacIbasI-Monrol Nuclear Products
- Nordion
- Advanced Accelerator Applications
- NTP Radioisotopes
- Curium Pharma
- Jubilant Life Sciences Ltd
- IRE - IRE ELiT - Instituto de Pesquisas Energeticas e Nucleares
- Australian Nuclear Science and Technology Organisation (ANSTO)
- Eckert & Ziegler Radiopharma GmbH
- Isotopia Molecular Imaging Ltd.
- Institute of Atomic Energy of Bangladesh
- Rosatom State Atomic Energy Corporation
- Board of Radiation and Isotope Technology (BRIT)
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Diagnostic Radioisotopes, By Radioisotope
- Market Diagnostic Radioisotopes, By Application
- Market Diagnostic Radioisotopes, By Imaging Modality
- Market Diagnostic Radioisotopes, By Indication
- Market Diagnostic Radioisotopes, By End User
- Market Diagnostic Radioisotopes, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders
- Restraints
- High cost of diagnostic radioisotopes
- Opportunities
- Increasing adoption of hybrid imaging techniques
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Diagnostic Radioisotopes Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Diagnostic Radioisotopes Market, By Radioisotope, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Technetium-99m
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Thallium-201
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Gallium-67
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Iodine-123
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- FDG
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Rubidium-82
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
6. Global Diagnostic Radioisotopes Market, By Application, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
- Diagnostic Application
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Therapeutic Application
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
7. Global Diagnostic Radioisotopes Market, By Imaging Modality, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
- SPECT
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- PET
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Beta Emitters
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
8. Global Diagnostic Radioisotopes Market, By Indication, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Thyroid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Orthopedic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Endocrinology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
9. Global Diagnostic Radioisotopes Market, By End User, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Academic & Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
10. Global Diagnostic Radioisotopes Market, By Region, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2032
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,( US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- GE Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Koninklijke Philips N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Cardinal Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Lantheus Holdings, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bayer AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bracco
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Eckert & Ziegler
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Nordion (Canada) Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- NTP Radioisotopes
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Curium
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Jubilant Life Sciences Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- IRE
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Isotopia Molecular Imaging Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Mallinckrodt Nuclear Medicine LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Jubilant DraxImage Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sumitomo Heavy Industries, Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Telix Pharmaceuticals Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
12. Section
- Research Methodology
- About us
샘플 요청 목록